卵母细胞成熟最后一天血清孕酮水平的临床显著日内变异性:一项重复测量的前瞻性研究
该前瞻性队列研究在22名卵母细胞捐献者中,于卵母细胞成熟最后一天(触发排卵前)的08:00、12:00、16:00和20:00四个时间点测量血清孕酮水平。结果显示孕酮从08:00至20:00平均下降44%(P<0.001);在08:00孕酮>1.5 ng/ml的10名患者中,70%(7名)在20:00降至<1.5 ng/ml。作者认为单次孕酮测定不足以做出临床决策。
要点
- 卵母细胞成熟最后一天孕酮水平从08:00至20:00平均下降44%(P<0.001)。
- 08:00孕酮>1.5 ng/ml者中,70%(7/10)在20:00降至<1.5 ng/ml。
- 孕酮日内下降与时间和重组FSH总剂量显著相关。
核心结论
- 卵母细胞成熟最后一天血清孕酮水平存在临床显著的日内变异性,平均下降达44%。
- 作者认为单次孕酮测定不可靠,不足以据此做出临床决策。
- 需进一步研究以明确卵泡期孕酮升高对IVF周期子宫内膜的影响。
研究设计与样本
- 前瞻性队列研究,在大学附属生育中心纳入22名卵母细胞捐献者。
- 研究时间为2017年11月至2018年1月。
- 在卵母细胞成熟最后一天的08:00、12:00、16:00和20:00(触发排卵前)重复测量血清孕酮。
- 所有对象采用灵活拮抗剂方案,并以重组卵泡刺激素(FSH)进行卵巢刺激。
主要发现
- 08:00、12:00、16:00和20:00的平均血清孕酮分别为1.75 ng/ml、1.40 ng/ml、1.06 ng/ml和0.97 ng/ml。
- 08:00与20:00的孕酮差值为0.77(95%CI 0.56-0.99),相当于平均孕酮值下降44%(P<0.001)。
- 08:00孕酮>1.5 ng/ml者(n=10)中,70%(n=7)在20:00降至<1.5 ng/ml。
- 混合模型分析显示,日内孕酮下降与时间和重组FSH总剂量显著相关。
临床怎么用
- 作者认为,由于日内孕酮变异巨大,卵母细胞成熟最后一天的单次孕酮测定不足以可靠地做出临床决策。
- 作者建议需进一步研究以明确卵泡期孕酮升高对IVF周期子宫内膜的影响。
局限性
- 仅纳入年轻健康、采用拮抗剂方案和重组FSH刺激的卵母细胞捐献者。
- 外推至采用不同刺激方案和促性腺激素的普通IVF人群尚需确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there significant variability in progesterone levels during the final day of oocyte maturation in women undergoing ovarian stimulation? SUMMARY ANSWER: Progesterone levels drop from the basal level up to 44% during the final day of oocyte maturation in women undergoing ovarian stimulation. WHAT IS KNOWN ALREADY: It has been suggested that elevated progesterone levels on the final day of ovarian stimulation may be related to poorer outcomes in in vitro fertilization fresh cycles due to a negative impact on the endometrium. However, despite conflicting results regarding the actual effect of progesterone on pregnancy rates and the lack of a well-established cut off, currently many IVF patients have their embryo transfer deferred when progesterone values surpass a threshold of 1.5 ng/ml on the day of ovulation triggering. STUDY DESIGN, SIZE, DURATION: This was a prospective cohort study conducted in 22 oocyte donors of a university-affiliated fertility centre between November 2017 and January 2018. We calculated the sample size to detect a difference of 15% between the first and last progesterone measurements with a 5% false-positive rate in a two-sided test with 80% statistical power and a 95% confidence interval (CI). PARTICIPANTS/MATERIALS, SETTING, METHODS: Progesterone circulating levels were evaluated at four different times during the final day of oocyte maturation (08:00, 12:00, 16:00 and 20:00) before ovulation triggering in healthy oocyte donors. A flexible antagonist protocol was used, and ovarian stimulation was achieved with recombinant follicle-stimulating hormone (FSH) in all cases. The pairwise percentage differences in progesterone levels for each patient were calculated. Univariate linear regression analysis was adopted in order to evaluate variables associated with progesterone levels on the first measurement. The intra-day variability of progesterone was analysed using mixed models. MAIN RESULTS AND THE ROLE OF CHANCE: Mean serum progesterone values at 08:00, 12:00, 16:00 and 20:00 were 1.75 ng/ml, 1.40 ng/ml, 1.06 ng/ml and 0.97 ng/ml. The progesterone difference between 08:00 and 20:00 was 0.77 (95% CI, 0.56-0.99), which is equivalent to a 44% decline in the mean progesterone values between the first (08:00) and the last determination (20:00; P < 0.001). Among those patients with basal (08:00) progesterone levels >1.5 ng/ml (n = 10), 70% (n = 7) showed levels reduced to <1.5 ng/ml on the last determination of the day (20:00). A mixed model analysis revealed that the progesterone reduction during the day was significantly associated with time and total recombinant FSH dose administered. LIMITATIONS, REASONS FOR CAUTION: Only young healthy oocyte donors stimulated with an antagonist protocol using recombinant FSH were included. Extrapolation to the general IVF population, with different stimulation protocols and gonadotropins, needs to be confirmed. WIDER IMPLICATIONS OF THE FINDINGS: This study suggests that a single progesterone determination on the final day of oocyte maturation is not reliable enough to make clinical decisions due to the enormous variation in progesterone during the day. Further studies are needed to better define the impact of the follicular progesterone rise on the endometrium of IVF cycles. STUDY FUNDING/COMPETING INTEREST(S): Funding was granted from Fundació Santiago Dexeus Font. N.P.P. received unrestricted grants and/or lectures fees from Roche Diagnostics, MSD, Merck, Ferring Pharmaceuticals, IBSA, Theramex and BESINS International, not associated with the current study. The remaining authors have no competing interests. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov NCT03366025.
引用
- González-Foruria I, Rodríguez I, Martínez F, et al. Clinically significant intra-day variability of serum progesterone levels during the final day of oocyte maturation: a prospective study with repeated measurements. Hum Reprod. 2019. PMID: 31334546. doi:10.1093/humrep/dez091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。